A*STAR SBIC spin-off Respiree

HOW SMART WEARABLE CAN HELP DETECT COVID-19

SBIC spin-off, Respiree's wearable is being used to detect symptoms of COVID-19.

SBIC Sarah Luo

Do our brains shape our diets?

SBIC's Dr Sarah Luo shares about her work in an interview for Singapore Today on radio channel CNA938.

1000-sbic-immunostaining

New target in liver cancer treatment

Researchers at SBIC have identified two metabolic enzymes as possible drug targets to inhibit cancer cell growth in hepatocellular carcinoma.

SBIC Metabolic Imaging MRI GUSTO

New perspectives in metabolic disease

MRI and MRS are powerful tools for for assessing body composition and measuring metabolic activity.

Image carousel SBIC

Imaging today the medicine of tomorrow

In close partnership with both industry and clinicians, researchers at SBIC are changing the way we see the human body to improve health and well-being.

Singapore Bioimaging Consortium(SBIC)



Singapore Bioimaging Consortium (SBIC) is one of the 10 research institutes of the Biomedical Research Council under the Agency for Science, Technology and Research (A*STAR) in Singapore. 


Located in Singapore’s premier international research and development hub for biomedical sciences, at the heart of Biopolis, the centre occupies 5 levels of the Helios building and is staffed by 130 multi-disciplinary imaging experts, including biologists, chemists, physicists, engineers and clinicians. SBIC is a national bioimaging hub for biomedical research. Equipped with state-of-the-art instruments, we lead strategic partnerships for technology developments.

Together with our academic, clinical and industrial partners, we develop bioimaging applications, as well as promote the co-ordination of national bioimaging efforts and initiatives.





A*STAR SBIC Team